Biotech

All Articles

Former Seagen CEO introduces brand new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) specialist Seagen was actually sold to Pfizer in 2014 for a mon...

Ironwood produces additional bid for $1B GI medicine along with new subgroup data

.On the heels of a phase 3 succeed that neglected to impress real estate investors, Ironwood Pharmac...

Novartis inks $150M offer for autoimmune molecular glue

.Do not stop Monte Rosa Therapeutics right now. The Boston-based biotech is actually having a ball a...

Jade takes exec crew along with Chinook veterinarians-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of substantial management hirings, shootings ...

Septerna goes public along with upsized offering of $288M

.Commemorating his business's upsized initial public offering (IPO), Septerna chief executive office...

AbbVie brings in Richter richer, paying out $25M to create finding pact

.AbbVie has returned to the source of its own antipsychotic goliath Vraylar searching for yet anothe...

GenSight goes into final full weeks of cash runway as earnings stream noses out of range

.GenSight Biologics is full weeks out of losing funds. Once again. The biotech just has enough money...

AZ licenses discarded rare condition medicine to Monopar Rehabs

.Monopar Therapies is actually recouping a drug from the scrap heap of AstraZeneca's rare illness pi...

Arcus' brand-new HIF-2a data in renal cancer cells hint at prospective edge over Merck's Welireg, experts point out

.With brand-new information out on Arcus Biosciences' experimental HIF-2a prevention, one team of an...

Roche wagers approximately $1B to grow Dyno gene treatment shipping pact

.After forming a gene therapy collaboration along with Dyno Rehabs in 2020, Roche is back for even m...